Prostate Cancer Drug Development Summit
Evvnt Promotion / evvnt
Archivo
17.08.2021 - 19.08.2021 Online
Time: 09:00 - 17:00
Temas de la conferencia
The inaugural virtual Prostate Cancer Drug Development Summit lands at a crucial time as the first and only dedicated conference for large pharma, biotech and pioneering academics to unite under a common and ambitious goal of accelerating the practical discovery, translation, and clinical development of safe and effective treatments for prostate cancer.
The inaugural virtual Prostate Cancer Drug Development Summit lands at a crucial time as the first and only dedicated conference for large pharma, biotech and pioneering academics to unite under a common and ambitious goal of accelerating the practical discovery, translation, and clinical development of safe and effective treatments for prostate cancer.
Organizador profesional (PCO)
Hanson Wade
Hanson Wade
Observaciones
Speakers: Ellen Filvaroff, Bristol-Myers Squibb, Vivek Arora, Bristol Myers Squibb, Alison Crawford, Regeneron Pharmaceuticals, Inc, Maggie Janat-Amsbury, Amgen, Andrew Cavey, Novartis/Advanced Accelerator Applications and more.
Speakers: Ellen Filvaroff, Bristol-Myers Squibb, Vivek Arora, Bristol Myers Squibb, Alison Crawford, Regeneron Pharmaceuticals, Inc, Maggie Janat-Amsbury, Amgen, Andrew Cavey, Novartis/Advanced Accelerator Applications and more.
Información e inscripción:
https://go.evvnt.com/757702-2?pid=4832
Ms. Jessica Durston
Medicina General
Idioma
Inglés
Inglés
Cuota del Congreso
USD 1799.0 - USD 3297.0
USD 1799.0 - USD 3297.0
Los participantes esperaban
1000
1000
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."
